ARCHIVES

DCE Advisors Okay Contract Recompetitions For Epidemiology

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt

November 17, 1978

Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.

April 27, 2007

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

ASCO Updates Guideline On Antiemetics

June 30, 2006